Welcome guest, Sign in


Brian M. Andersen


Ph.D. in Neuroscience, University of Minnesota, 2013

Current position

M.D. candidate, Medical Scientist Training Program, University of Minnesota (anticipated graduation on May, 2015)


  1. Andersen, B. M., Pluhar, G. E., Seiler, C. E., Goulart, M. R., SantaCruz, K. S., Schutten, M. M., Meints, J. P., O'Sullivan, M. G., Bentley, R. T., Packer, R. A., Thomovsky, S. A., Chen, A. V., Faissler, D., Chen, W., Hunt, M. A., Olin, M. R. and Ohlfest, J. R. (2013). Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity. Cancer Res 73(10): 2987-2997.
  2. Ohlfest, J. R., Andersen, B. M., Litterman, A. J., Xia, J., Pennell, C. A., Swier, L. E., Salazar, A. M. and Olin, M. R. (2013). Vaccine injection site matters: qualitative and quantitative defects in CD8 T cells primed as a function of proximity to the tumor in a murine glioma model. J Immunol 190(2): 613-620.
  3. Andersen, B. M. and Ohlfest, J. R. (2012). Increasing the efficacy of tumor cell vaccines by enhancing cross priming. Cancer Lett 325(2): 155-164.
  4. Olin, M. R., Andersen, B. M., Litterman, A. J., Grogan, P. T., Sarver, A. L., Robertson, P. T., Liang, X., Chen, W., Parney, I. F., Hunt, M. A., Blazar, B. R. and Ohlfest, J. R. (2011). Oxygen is a master regulator of the immunogenicity of primary human glioma cells. Cancer Res 71(21): 6583-6589.
  5. Olin, M. R., Andersen, B. M., Zellmer, D. M., Grogan, P. T., Popescu, F. E., Xiong, Z., Forster, C. L., Seiler, C., SantaCruz, K. S., Chen, W., Blazar, B. R. and Ohlfest, J. R. (2010). Superior efficacy of tumor cell vaccines grown in physiologic oxygen. Clin Cancer Res 16(19): 4800-4808.
  6. Nordstrom, L. J., Clark, C. A., Andersen, B., Champlin, S. M. and Schwinefus, J. J. (2006). Effect of ethylene glycol, urea, and N-methylated glycines on DNA thermal stability: the role of DNA base pair composition and hydration. Biochemistry 45(31): 9604-9614.
Protocols by Brian M. Andersen
  1. Detection of Tumor Cell Surface-reactive Antibodies